(Q41008100)

25 September 2017

Investigation of IVS14 + 1G > A polymorphism of DPYD gene in a group of Bosnian patients treated with 5-Fluorouracil and capecitabine (English)

1 reference

25 September 2017

1 reference

1 reference

Timur Cerić

1

1 reference

25 September 2017

Nermina Obralić

2

1 reference

25 September 2017

Lejla Kapur-Pojskić

3

1 reference

25 September 2017

Drazenka Macić

4

1 reference

25 September 2017

Semir Beslija

5

1 reference

25 September 2017

Anes Pasić

6

1 reference

25 September 2017

Sejla Cerić

7

1 reference

25 September 2017

1 May 2010

1 reference

Bosnian Journal of Basic Medical Sciences

25 September 2017

1 reference

25 September 2017

10

1 reference

25 September 2017

2

1 reference

25 September 2017

133-139

1 reference

Pharmacogenetics goes genomic

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5509399

Pharmacogenetic and clinical aspects of dihydropyrimidine dehydrogenase deficiency

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5509399

Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene.

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5509399

Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5509399

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5509399

5-Fluorouracil toxicity-attributable IVS14 + 1G > A mutation of the dihydropyrimidine dehydrogenase gene in Polish colorectal cancer patients.

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5509399

Using pharmacogenetics to improve drug safety and efficacy

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5509399

Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5509399

Nomenclature for human DPYD alleles

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5509399

Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5509399

Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20507294

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.17305/BJBMS.2010.2712

0 references

1 reference

25 September 2017

PubMed publication ID

20507294

1 reference